ARTICLE | Company News

Harbour BioMed in antibody deal with BeiGene

January 12, 2018 4:59 PM UTC

Harbour BioMed (Shanghai, China) granted BeiGene Ltd. (NASDAQ:BGNE) a license to access its H2L2 transgenic mouse platform for use in multiple programs over a multi-year period. Harbour's H2L2 mice g...

BCIQ Company Profiles

BeiGene Ltd.

HBM Holdings Ltd.